{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T12:36:44Z","timestamp":1717072604906},"reference-count":13,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.medcli.2009.05.042","type":"journal-article","created":{"date-parts":[[2009,11,13]],"date-time":"2009-11-13T09:14:46Z","timestamp":1258103686000},"page":"72-75","source":"Crossref","is-referenced-by-count":4,"title":["Doxorrubicina liposomal no pegilada en combinaci\u00f3n con ciclofosfamida, vincristina, prednisona y rituximab en el tratamiento de linfomas no hodgkinianos: estudio de 26 pacientes"],"prefix":"10.1016","volume":"134","author":[{"given":"Miriam","family":"Moreno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan-Manuel","family":"Sancho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Gardella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Coll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Gallardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep-Mar\u00eda","family":"Ribera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2009.05.042_bib1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2009.05.042_bib2","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1200\/JCO.2004.06.033","article-title":"Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults","volume":"22","author":"Hequet","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.medcli.2009.05.042_bib3","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1200\/JCO.1998.16.6.2070","article-title":"Late effects in long-term survivors of high-grade non-Hodgkin's lymphomas","volume":"16","author":"Haddy","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.medcli.2009.05.042_bib4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/annonc\/mdg070","article-title":"Early cardiotoxicity of the CHOP regimen in aggressive non-Hodgkin lymphoma","volume":"14","author":"Limat","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.medcli.2009.05.042_bib5","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1200\/JCO.2001.19.5.1444","article-title":"Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophophamide in a randomized, multicenter trial of metastasic breast cancer","volume":"19","author":"Batist","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.medcli.2009.05.042_bib6","article-title":"A phase i\/ii trial of liposomal doxorubicin (TLC D-99, Myocet) with cyclophosphamide, vincristine, and prednisone in newly diagnosed aggressive non-Hodgkins lymphoma (NHL)","volume":"21","author":"Levine","year":"2002","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.medcli.2009.05.042_bib7","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1200\/JCO.2004.10.093","article-title":"Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS-Related non-Hodgkin's lymphoma: Results of therapy and correlates of response","volume":"12","author":"Levine","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.medcli.2009.05.042_bib8","unstructured":"Herrero J, G\u00f3mez-Codina J, Provencio M, Rueda A, Llanos M, Lobo F, et al. Primera valoraci\u00f3n de eficacia de un estudio de fase ii con ciclofosfamida, vincristina, doxorrubicina lipos\u00f3mica y prednisona m\u00e1s rituximab, administrados cada 2 semanas (R-COMP\/14) como tratamiento primario del LNH. J Clin Oncol, 2007 ASCO Annual Meeting Proceedings Part I. 2007;25:18519."},{"key":"10.1016\/j.medcli.2009.05.042_bib9","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/hon.827","article-title":"Liposome-encapsulated doxorubicin in combination with ciclophophamide, vincristine, prednisone and rituximab in patients with lymphoma and concurrent cardiac disease or pre-treated with anthracyclines","volume":"25","author":"Rigacci","year":"2007","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.medcli.2009.05.042_bib10","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1080\/10428190802043853","article-title":"R-COMP 21 for frail elderly patients with aggressive non-Hodgkin lymphoma: A pilot study","volume":"49","author":"Visani","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.medcli.2009.05.042_bib11","article-title":"Reduced dose of non-pegylated liposomal doxorrubicin with ciclophosphamide, vincristine and prednisone \u00b1 rituximab for elderly patients with aggressive lymphoma non candidates to standard chemotherapy","volume":"110","author":"Gimeno","year":"2007","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"key":"10.1016\/j.medcli.2009.05.042_bib12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1586\/14737140.9.3.357","article-title":"Non pegylated liposomal doxorubicin in the treatment of B-cell non-Hodgkin's lymphoma: Where we stand","volume":"9","author":"Visani","year":"2009","journal-title":"Expert Rev anticancer Ther"},{"key":"10.1016\/j.medcli.2009.05.042_bib13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2307\/2281868","article-title":"Non parametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Statist Assoc"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002577530901344X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002577530901344X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T20:34:31Z","timestamp":1558643671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002577530901344X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S002577530901344X"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2009.05.042","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}